{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:45:32Z","timestamp":1793047532729,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00702-008-0030-y","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T15:27:30Z","timestamp":1202743650000},"page":"1001-1009","source":"Crossref","is-referenced-by-count":220,"title":["Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA"],"prefix":"10.1007","volume":"115","author":[{"given":"A. L.","family":"Bartels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T. M.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C. H.","family":"van Oostrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Portman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,12]]},"reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0041-008X(96)80035-4","volume":"141","author":"LJ Bain","year":"1996","unstructured":"Bain LJ, LeBlanc GA (1996) Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol Appl Pharmacol 141:288\u2013298","journal-title":"Toxicol Appl Pharmacol"},{"key":"30_CR2","doi-asserted-by":"crossref","unstructured":"Bartels AL, van Berckel BNM, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL (2007) Blood\u2013brain barrier P-glycoprotein function is not impaired in early Parkinson\u2019s disease. Final stage of review ed","DOI":"10.1016\/j.parkreldis.2007.11.007"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molimm.2004.07.005","volume":"42","author":"GS Begley","year":"2005","unstructured":"Begley GS, Horvath AR, Taylor JC, Higgins CF (2005) Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol 42:137\u2013141","journal-title":"Mol Immunol"},{"key":"30_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E (2000) Pathoanatomy of Parkinson\u2019s disease. J Neurol 247:3\u201310","journal-title":"J Neurol"},{"key":"30_CR5","doi-asserted-by":"crossref","unstructured":"Burn DJ (2006) Parkinson\u2019s disease dementia: what\u2019s in a Lewy body? J Neural Transm Suppl 361\u2013365","DOI":"10.1007\/978-3-211-45295-0_55"},{"issue":"Suppl 12","key":"30_CR6","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1002\/mds.20553","volume":"20","author":"D Caparros-Lefebvre","year":"2005","unstructured":"Caparros-Lefebvre D, Lees AJ (2005) Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis. Mov Disord 20(Suppl 12):S114\u2013S118","journal-title":"Mov Disord"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","volume":"86","author":"C Cordon-Cardo","year":"1989","unstructured":"Cordon-Cardo C, O\u2019Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood\u2013brain barrier sides. Proc Natl Acad Sci USA 86:695\u2013698","journal-title":"Proc Natl Acad Sci USA"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.38.10.1546","volume":"38","author":"PH Davis","year":"1988","unstructured":"Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS (1988) Risk factors for progressive supranuclear palsy. Neurology 38:1546\u20131552","journal-title":"Neurology"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","volume":"56","author":"ECM Lange de","year":"2004","unstructured":"de Lange ECM (2004) Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56:1793\u20131809","journal-title":"Adv Drug Deliv Rev"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"TK Del","year":"2002","unstructured":"Del TK, Rub U, de Vos RA, Bohl JR Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1006\/bbrc.2001.4312","volume":"281","author":"M Demeule","year":"2001","unstructured":"Demeule M, Labelle M, Regina A, Berthelet F, Beliveau R (2001) Isolation of endothelial cells from brain, lung, and kidney: Expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun 281:827\u2013834","journal-title":"Biochem Biophys Res Commun"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-200305000-00004","volume":"13","author":"M Drozdzik","year":"2003","unstructured":"Drozdzik M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J, Sych Z (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson\u2019s disease. Pharmacogenetics 13:259\u2013263","journal-title":"Pharmacogenetics"},{"key":"30_CR13","first-page":"359","volume":"7","author":"C Fernandez","year":"2004","unstructured":"Fernandez C, Buyse M, German-Fattal M, Gimenez F (2004) Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharm Sci 7:359\u2013371","journal-title":"J Pharm Pharm Sci"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/jcbfm.1991.122","volume":"11","author":"KJ Friston","year":"1991","unstructured":"Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ (1991) Comparing functional (pet) images\u2014the assessment of significant change. J Cereb Blood Flow Metab 11:690\u2013699","journal-title":"J Cereb Blood Flow Metab"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CPP38069","volume":"38","author":"MF Fromm","year":"2000","unstructured":"Fromm MF (2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38:69\u201374","journal-title":"Int J Clin Pharmacol Ther"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00008571-200210000-00004","volume":"12","author":"T Furuno","year":"2002","unstructured":"Furuno T, Landi MT, Ceroni M, Caporaso N, Bernucci I, Nappi G, Martignoni E, Schaeffeler E, Eichelbaum M, Schwab M, Zanger UM (2002) Expression polymorphism of the blood\u2013brain barrier component P-glycoprotein (MDR1) in relation to Parkinson\u2019s disease. Pharmacogenetics 12:529\u2013534","journal-title":"Pharmacogenetics"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33\u201339","journal-title":"Arch Neurol"},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"A270","DOI":"10.1212\/WNL.56.2.270","volume":"56","author":"A Gerhard","year":"2001","unstructured":"Gerhard A, Banati RB, Cagnin A, Brooks DJ (2001) In vivo imaging of activated microglia with [C-11]PK11195 positron emission tomography (PET) in idiopathic and atypical Parkinson\u2019s disease. Neurology 56:A270","journal-title":"Neurology"},{"key":"30_CR19","first-page":"425","volume":"14","author":"S Gilman","year":"1999","unstructured":"Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G (1999) Consensus on the diagnosis of multi-system atrophy. Neurologia 14:425\u2013428","journal-title":"Neurologia"},{"key":"30_CR20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1212\/01.WNL.0000031426.21683.E2","volume":"59","author":"J Green","year":"2002","unstructured":"Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, Haber M, Bakay RA, Triche S, Sirockman B, DeLong MR (2002) Cognitive impairments in advanced PD without dementia. Neurology 59:1320\u20131324","journal-title":"Neurology"},{"key":"30_CR21","first-page":"261P","volume":"40","author":"NH Hendrikse","year":"1999","unstructured":"Hendrikse NH, Vaalburg W, De Vries EG, Van der Graaf WT, Willemsen AT (1999) Quantification of in-vivo P-glycoprotein facilitated transport in the blood\u2013brain barrier. J Nucl Med 40:261P\u2013262P","journal-title":"J Nucl Med"},{"key":"30_CR22","doi-asserted-by":"crossref","unstructured":"Hendrikse NH, Bart J, De Vries EGE, Groen HJM, Van der Graaf WTA, Vaalburg W (2001) P-glycoprotein at the blood\u2013brain barrier and analysis of drug transport with positron-emission tomography. J Clin Pharmacol 48S\u201354S","DOI":"10.1177\/009127001773744152"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.0306-5251.2001.01516.x","volume":"53","author":"M Hennessy","year":"2002","unstructured":"Hennessy M, Kelleher D, Spiers JP, Barry M, Kavanagh P, Back D, Mulcahy F, Feely J (2002) St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 53:75\u201382","journal-title":"Br J Clin Pharmacol"},{"issue":"Pt 4","key":"30_CR24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1469-7580.2000.19640609.x","volume":"196","author":"WG Johnson","year":"2000","unstructured":"Johnson WG (2000) Late-onset neurodegenerative diseases\u2013the role of protein insolubility. J Anat 196(Pt 4):609\u2013616","journal-title":"J Anat"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JCH, Vaalburg W, Bart J, Willemsen ATM, Hendrikse NH (2005) Blood\u2013brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol 57:176\u2013179","journal-title":"Ann Neurol"},{"key":"30_CR26","doi-asserted-by":"crossref","unstructured":"Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW, Vogelgesang S (2007) MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer\u2019s amyloid-beta peptides-implications for the mechanisms of Abeta clearance at the blood\u2013brain Barrier. Brain Pathol (4):347-353","DOI":"10.1111\/j.1750-3639.2007.00075.x"},{"key":"30_CR27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","volume":"76","author":"FC Lam","year":"2001","unstructured":"Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB (2001) beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121\u20131128","journal-title":"J Neurochem"},{"key":"30_CR28","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnen\/63.10.1038","volume":"63","author":"D Langford","year":"2004","unstructured":"Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E (2004) Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol 63:1038\u20131047","journal-title":"J Neuropathol Exp Neurol"},{"key":"30_CR29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1212\/01.wnl.0000196863.43951.44","volume":"66","author":"JM Lee","year":"2006","unstructured":"Lee JM, Markus HS (2006) Does the white matter matter in Alzheimer disease and cerebral amyloid angiopathy? Neurology 66:6\u20137","journal-title":"Neurology"},{"key":"30_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS, Chase TN, FitzGibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller P, Reich SG, Verny M (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47:1\u20139","journal-title":"Neurology"},{"key":"30_CR31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661\u2013670","journal-title":"Nucl Med Biol"},{"key":"30_CR32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00002093-199803001-00001","volume":"12","author":"PL Mcgeer","year":"1998","unstructured":"Mcgeer PL, Mcgeer EG (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord 12:S1\u2013S6","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"30_CR33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL Mcgeer","year":"2004","unstructured":"Mcgeer PL, Mcgeer EG (2004) Inflammation and neurodegeneration in Parkinson\u2019s disease. Parkinsonism Relat Disord 10:S3\u2013S7","journal-title":"Parkinsonism Relat Disord"},{"key":"30_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/DMR-120018247","volume":"35","author":"MP Mcrae","year":"2003","unstructured":"Mcrae MP, Brouwer KLR, Kashuba ADM (2003) Cytokine regulation of P-glycoprotein. Drug Metab Rev 35:19\u201333","journal-title":"Drug Metab Rev"},{"key":"30_CR35","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1073\/pnas.0611231104","volume":"104","author":"G Morfini","year":"2007","unstructured":"Morfini G, Pigino G, Opalach K, Serulle Y, Moreira JE, Sugimori M, Llinas RR, Brady ST (2007) 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci USA 104:2442\u20132447","journal-title":"Proc Natl Acad Sci USA"},{"key":"30_CR36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2353\/ajpath.2007.060359","volume":"170","author":"EH Norris","year":"2007","unstructured":"Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM (2007) Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol 170:658\u2013666","journal-title":"Am J Pathol"},{"key":"30_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.1995.00540260097023","volume":"52","author":"P Piccini","year":"1995","unstructured":"Piccini P, Pavese N, Canapicchi R, Paoli C, Del DP, Puglioli M, Rossi G, Bonuccelli U (1995) White matter hyperintensities in Parkinson\u2019s disease. Clin Correlat Arch Neurol 52:191\u2013194","journal-title":"Clin Correlat Arch Neurol"},{"key":"30_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/WNL.56.1.4","volume":"56","author":"AH Rajput","year":"2001","unstructured":"Rajput AH (2001) Environmental toxins accelerate Parkinson\u2019s disease onset. Neurology 56:4\u20135","journal-title":"Neurology"},{"key":"30_CR39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03402043","volume":"9","author":"AE Roher","year":"2003","unstructured":"Roher AE, Kuo YM, Esh C, Knebel C, Weiss N, Kalback W, Luehrs DC, Childress JL, Beach TG, Weller RO, Kokjohn TA (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease. Mol Med 9:112\u2013122","journal-title":"Mol Med"},{"key":"30_CR40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"30_CR41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2004.09.046","volume":"372","author":"EK Tan","year":"2004","unstructured":"Tan EK, Drozdzik M, Bialecka M, Honczarenko K, Klodowska-Duda G, Teo Y, Tang K, Wong LP, Chong SS, Tan C, Yew K, Zhao Y, Lee CGL (2004) Analysis of MDR1 haplotypes in Parkinson\u2019s disease in a white population. Neurosci Lett 372:240\u2013244","journal-title":"Neurosci Lett"},{"key":"30_CR42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00001622-200009000-00011","volume":"12","author":"B Tan","year":"2000","unstructured":"Tan B, Piwnica-Worms D, Ratner L (2000) Multidrug resistance transporters and modulation. Curr Opin Oncol 12:450\u2013458","journal-title":"Curr Opin Oncol"},{"key":"30_CR43","unstructured":"Tan KH, Purcell WM, Heales SJR, Mcleod JD, Hurst RD (2002) Activated T cells modulate P-glycoprotein expression in an in vitro model of the blood\u2013brain barrier. J Physiol (London) 539:89P"},{"key":"30_CR44","first-page":"545","volume":"102","author":"S Vogelgesang","year":"2001","unstructured":"Vogelgesang S, Cascorbi I, Kroemer HK, Schroeder E, Pahnke J, Siegmund W, Keil C, Warzok RW, Walker LC (2001) Deposition of amyloid is inversely correlated with the expression of p-glycoprotein\u2014implications on the possibility of prevention of Alzheimer\u2019s disease. Acta Neuropathol 102:545","journal-title":"Acta Neuropathol"},{"key":"30_CR45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00401-006-0042-3","volume":"111","author":"S Vogelgesang","year":"2006","unstructured":"Vogelgesang S, Glatzel M, Walker LC, Kroemer HK, Aguzzi A, Warzok RW (2006a) Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt\u2013Jakob disease. Acta Neuropathol (Berl) 111:436\u2013443","journal-title":"Acta Neuropathol (Berl)"},{"key":"30_CR46","first-page":"365","volume":"112","author":"S Vogelgesang","year":"2006","unstructured":"Vogelgesang S, Kuhnke D, Jedlitschky G, Jucker M, Mosyagin I, Pahnke J, Cascorbi I, Kroemer HK, Walker LC, Warzok RW (2006b) P-glycoprotein (ABCB1) mediates transport of Alzheimer\u2019s beta-amyloid peptides. Acta Neuropathol 112:365\u2013367","journal-title":"Acta Neuropathol"},{"key":"30_CR47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0969-8043(02)00143-4","volume":"57","author":"TD Wegman","year":"2002","unstructured":"Wegman TD, Maas B, Elsinga PH, Vaalburg W (2002) An improved method for the preparation of [C-11]verapamil. Appl Radiat Isot 57:505\u2013507","journal-title":"Appl Radiat Isot"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0030-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:34:15Z","timestamp":1557275655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0030-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,12]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0030-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,12]]}}}